James Investment Research »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by James Investment Research

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by James Investment Research from 13F filings

Historical chart of James Investment Research investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by James Investment Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by James Investment Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $290k 7.0k 41.25
2025-09-30 $273k 7.0k 38.83

More positions owned by James Investment Research

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Gold Tr Ishares New (IAU)
Enova Intl (ENVA)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Caterpillar (CAT)
NOVA MEASURING Instruments L (NVMI)
Broadcom (AVGO)
Amazon (AMZN)
Goldman Sachs (GS)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)

View all positions for James Investment Research

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Millennium Management
FMR
Pictet Asset Management Holding SA
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners
Driehaus Capital Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A